Ascendis Pharma A (ASND) Change in Working Capital (2015 - 2021)
Ascendis Pharma A (ASND) posted Change in Working Capital of $2.4 million for Q1 2021, up 104.95% sequentially from -$48.3 million in Q3 2020.
Ascendis Pharma A (ASND) Change in Working Capital (2015 - 2021) Analysis & Trends
Ascendis Pharma A has reported Change in Working Capital for 7 years, with the latest figure at $2.4 million in Q1 2021.
- Quarterly Change in Working Capital changed N/A year-over-year to $2.4 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$45.9 million (changed N/A YoY) and the FY2020 annual result came in at -$37.4 million, down 5.36% from the prior year.
- Change in Working Capital grew to $2.4 million in Q1 2021 per ASND's latest filing, from -$48.3 million in the prior quarter.
- Over five years, Change in Working Capital peaked at $2.4 million in Q1 2021 and troughed at -$48.3 million in Q3 2020.
- A 5-year average of -$15.4 million and a median of -$9.2 million in 2017 frame the typical range for Change in Working Capital.
- The widest YoY moves for Change in Working Capital: up 85.95% in 2017, down 6509.53% in 2017.
- Over 5 years, Change in Working Capital stood at -$1.4 million in 2017, then sank by 1061.91% to -$16.1 million in 2018, then slumped by 123.58% to -$36.0 million in 2019, then tumbled by 34.04% to -$48.3 million in 2020, then jumped by 104.95% to $2.4 million in 2021.
- According to Business Quant data, Change in Working Capital over the past three periods registered $2.4 million, -$48.3 million, and -$36.0 million for Q1 2021, Q3 2020, and Q1 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.39 Mn |
| Mar 31, 2021 | 2.39 Mn |
| Sep 30, 2020 | -48.30 Mn |
| Sep 30, 2020 | -48.30 Mn |
| Mar 31, 2019 | -36.03 Mn |
| Mar 31, 2019 | -36.03 Mn |
| Mar 31, 2018 | -16.12 Mn |
| Mar 31, 2018 | -16.12 Mn |
| Dec 31, 2017 | -1.39 Mn |
| Dec 31, 2017 | -1.39 Mn |
| Sep 30, 2017 | -9.23 Mn |
| Sep 30, 2017 | -9.23 Mn |
| Mar 31, 2017 | 686,122.04 |
| Mar 31, 2017 | 686,122.04 |
| Dec 31, 2016 | -9.87 Mn |
| Dec 31, 2016 | -9.87 Mn |
| Sep 30, 2016 | 143,987.80 |
| Sep 30, 2016 | 143,987.80 |
| Mar 31, 2015 | -9.49 Mn |
| Mar 31, 2015 | -9.49 Mn |